Aveanna Healthcare Holdings Inc. (AVAH)
| Market Cap | 1.41B +20.4% |
| Revenue (ttm) | 2.52B +20.5% |
| Net Income | 261.49M +4,710.4% |
| EPS | 1.20 +4,155.5% |
| Shares Out | 217.76M |
| PE Ratio | 5.41 |
| Forward PE | 9.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,022,448 |
| Open | 7.16 |
| Previous Close | 6.67 |
| Day's Range | 6.45 - 7.26 |
| 52-Week Range | 3.73 - 10.32 |
| Beta | 1.93 |
| Analysts | Buy |
| Price Target | 10.05 (+55.33%) |
| Earnings Date | May 14, 2026 |
About AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for AVAH stock is "Buy." The 12-month stock price target is $10.05, which is an increase of 55.33% from the latest price.
News
Aveanna Healthcare Holdings Transcript: 46th Annual William Blair Growth Stock Conference
Fourteen consecutive quarters of outperformance and strategic acquisitions have driven strong revenue and EBITDA growth, with updated 2026 guidance reflecting recent M&A. Preferred payer and value-based strategies underpin stable, diversified growth, while disciplined financial management supports ongoing de-leveraging and expansion.
Aveanna raises FY26 revenue view to $2.63B-$2.65B from $2.56B-$2.58B
Consensus $2.6B. Raises FY26 adjusted EBITDA view to $338M-$342M from $328M-$332M. Aveanna (AVAH) announced that it completed its acquisition of Family First Holding. Aveanna acquired Family First Hom...
Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance
ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient ...
Aveanna Healthcare Announces Successful Debt Repricing
ATLANTA, May 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, high-c...
Aveanna price target raised to $9 from $8 at Truist
Truist analyst David MacDonald raised the firm’s price target on Aveanna (AVAH) to $9 from $8 and keeps a Hold rating on the shares after its Q1 earnings beat. Cor…
Aveanna price target lowered to $9 from $9.50 at Barclays
Barclays lowered the firm’s price target on Aveanna (AVAH) to $9 from $9.50 and keeps an Overweight rating on the shares post the Q1 report. The firm upped the company’s’…
Aveanna price target raised to $10 from $9 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on Aveanna (AVAH) to $10 from $9 and keeps a Sector Perform rating on the shares. The company delivered a…
Aveanna upgraded to Overweight at Stephens on ‘beat-and-raise’ momentum
As previously reported, Stephens analyst Scott Fidel upgraded Aveanna (AVAH) to Overweight from Equal Weight with a price target of $11, up from $10. Aveanna has delivered a “sustained cadence…
Aveanna upgraded to Overweight from Equal Weight at Stephens
Stephens upgraded Aveanna (AVAH) to Overweight from Equal Weight with an $11 price target
Aveanna Healthcare Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 15.9% revenue growth and 25.2% adjusted EBITDA growth, driven by preferred payer strategies and operational efficiencies. Guidance for 2026 was raised, and the Family First Homecare acquisition is set to close in late Q2.
Aveanna Healthcare Holdings Earnings release: Q1 2026
Aveanna Healthcare Holdings released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Aveanna Healthcare Holdings Quarterly report: Q1 2026
Aveanna Healthcare Holdings has published its Q1 2026 quarterly earnings report on May 14, 2026.
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 million for the prior year period Adjusted EBITDA for ...
Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
ATLANTA, May 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the William Blair 46th Annual Growth Stock Co...
Aveanna Healthcare Holdings Slides: Investor presentation
Aveanna Healthcare Holdings has posted slides in relation to its latest quarterly earnings report, which was published on May 12, 2026.
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30th Annual Leveraged Finance ...
Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open o...
Aveanna Healthcare Holdings Proxy statement: Proxy filing
Aveanna Healthcare Holdings filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.
Aveanna Healthcare Holdings Proxy statement: Proxy filing
Aveanna Healthcare Holdings filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.
Aveanna price target lowered to $8 from $9 at Truist
Truist analyst David MacDonald lowered the firm’s price target on Aveanna (AVAH) to $8 from $9 and keeps a Hold rating on the shares as part of a broader research…
Aveanna price target lowered to $9.50 from $11 at Barclays
Barclays lowered the firm’s price target on Aveanna (AVAH) to $9.50 from $11 and keeps an Overweight rating on the shares. The firm revised models in the healthcare facilities and…
Aveanna price target lowered to $9 from $11 at RBC Capital
RBC Capital lowered the firm’s price target on Aveanna (AVAH) to $9 from $11 and keeps a Sector Perform rating on the shares. Despite solid Q4 results and maintained guidance,…
Aveanna upgraded to Strong Buy from Outperform at Raymond James
Raymond James upgraded Aveanna (AVAH) to Strong Buy from Outperform with an unchanged price target of $13. The firm views the current valuation as “a discount to precedent transactions” with…
Aveanna price target lowered to $10 from $11 at BMO Capital
BMO Capital analyst Sean Dodge lowered the firm’s price target on Aveanna (AVAH) to $10 from $11 and keeps an Outperform rating on the shares. The company’s Q4 results were…
Aveanna price target lowered to $9 from $10 at Truist
Truist lowered the firm’s price target on Aveanna (AVAH) to $9 from $10 and keeps a Hold rating on the shares. The company reported a strong Q4, consistent with its…